| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/30/2009 | US20090192134 Compounds |
| 07/30/2009 | US20090192130 Method for Treating Uterine Fibroids |
| 07/30/2009 | US20090192127 Combination therapy comprising a diaryl urea compound and a p13, akt kinase or mtor inhibitors (rapamycins) for cancer treatment |
| 07/30/2009 | US20090192112 Compositions and methods for treating cancer |
| 07/30/2009 | US20090192111 miR-124 Regulated Genes and Pathways as Targets for Therapeutic Intervention |
| 07/30/2009 | US20090192109 Compositions for diagnosis and therapy of diseases associated with aberrant expression of Kremen and/or Wnt |
| 07/30/2009 | US20090192108 Gene overexpressed in cancer |
| 07/30/2009 | US20090192107 Breast Cancer Markers |
| 07/30/2009 | US20090192105 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCELIC ACID (siNA) |
| 07/30/2009 | US20090192102 miR-21 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
| 07/30/2009 | US20090192101 Cancer-specific promoters |
| 07/30/2009 | US20090192098 Method for treating hematopoietic neoplasms |
| 07/30/2009 | US20090192089 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 07/30/2009 | US20090192088 Vascular Endothelial Growth Factor 2 |
| 07/30/2009 | US20090192087 Methods and Compositions Using Klotho-FGF Fusion Polypeptides |
| 07/30/2009 | US20090192085 FKBP-L And Uses Thereof |
| 07/30/2009 | US20090191640 Methods of Screening for Atherosclerosis |
| 07/30/2009 | US20090191572 Imaging, diagnosis and treatment of disease |
| 07/30/2009 | US20090191262 Use of compounds of formula a-r-xo pharmaceutically acceptable salts thereof for producing a pharmaceutically preparations |
| 07/30/2009 | US20090191237 Methods and reagents for vaccination which generate A CD8 T cell immune response |
| 07/30/2009 | US20090191232 Combination therapy for the treatment of tumors |
| 07/30/2009 | US20090191230 Cascade |
| 07/30/2009 | US20090191225 Fusion proteins; homogeneous purity, and unaltered affinity, and can be produced in high yields without the requirement of extensive purification; stable in serum to allow in vivo applications |
| 07/30/2009 | US20090191224 Nucleolin-Mediated Cancer Diagnostics and Therapy |
| 07/30/2009 | US20090191215 Treatment with anti-VEGF Antibodies |
| 07/30/2009 | US20090191211 METHODS FOR DAMAGING CELLS USING EFFECTOR FUNCTIONS OF ANTI-EphA4 ANTIBODIES |
| 07/30/2009 | US20090191210 Method for inhibiting tumor invasion or spreading in a subject |
| 07/30/2009 | US20090191201 Combination of the application of antibodies for immunostimulation together with glucocorticoids |
| 07/30/2009 | US20090191197 Cancerous disease modifying antibodies |
| 07/30/2009 | US20090191193 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof |
| 07/30/2009 | US20090191188 Immunostimulatory nucleic acids |
| 07/30/2009 | US20090191181 Methods of modulating smyd3 for treatment of cancer |
| 07/30/2009 | US20090191172 Method of Controlling Administration of Cancer Antigen |
| 07/30/2009 | US20090191160 Methods of producing pluripotent stem-like cells |
| 07/30/2009 | US20090191152 Intralymphatic chemotherapy drug carriers |
| 07/30/2009 | US20090191146 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 07/30/2009 | US20090191130 De novo synthesis of bacteriochlorins |
| 07/30/2009 | US20090191118 Cytotoxicity mediation of cells evidencing surface expression of TROP-2 |
| 07/30/2009 | US20090191117 Anti-Integrin Antibodies, Compositions, Methods and Uses |
| 07/30/2009 | DE102007057718A1 New heteroaryl-substituted piperidine compounds are protease-activated receptor antagonists useful for the treatment and/or prophylaxis of e.g. cardiovascular diseases, thromboembolic diseases, tumors, stroke, hypertension and asthma |
| 07/30/2009 | CA2713137A1 Targeting of innate immune response to tumor site |
| 07/30/2009 | CA2713126A1 Lytic domain fusion constructs and methods of making and using same |
| 07/30/2009 | CA2713111A1 4-pyridinone compounds and their use for cancer |
| 07/30/2009 | CA2712959A1 Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activity |
| 07/30/2009 | CA2712791A1 Fused pyridines active as inhibitors of c-met |
| 07/30/2009 | CA2712748A1 13,13-dimethyl-des-c,d analogs of 1.alpha.,25-dihydroxy-19-nor-vitamin d3 compounds and topical composition dosage forms and methods of treating skin conditions thereof |
| 07/30/2009 | CA2712612A1 4-(pyrrolo[2,3-c]pyridine-3-yl)pyrimidin-2-ylamine derivatives |
| 07/30/2009 | CA2712604A1 Iap inhibitors |
| 07/30/2009 | CA2712388A1 Salt forms of a 6-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene derivative, process for their manufacture and pharmaceutical compositions containing same |
| 07/30/2009 | CA2712087A1 Method of optimizing the treatment of proliferative diseases mediated by the tyrosine kinase receptor kit with imatinib |
| 07/30/2009 | CA2711629A1 Thienopyridazine compounds, their preparations, pharmaceutical compositions and uses |
| 07/30/2009 | CA2709806A1 Protein kinase inhibitors and use thereof |
| 07/30/2009 | CA2708175A1 Phthalazinone derivatives |
| 07/30/2009 | CA2704128A1 Novel composition for treating the side effects of anticancer treatments |
| 07/29/2009 | EP2083272A1 Cancer cell identification marker and cancer cell proliferation inhibitor |
| 07/29/2009 | EP2083076A1 In vitro differentiation/induction of lymphocyte from stem cell having genotype provided after gene reconstitution |
| 07/29/2009 | EP2083018A2 Compositions and methods relating to STOP-1 |
| 07/29/2009 | EP2083014A2 Inhibitors of interleukin-1ß converting enzyme |
| 07/29/2009 | EP2083011A1 Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 07/29/2009 | EP2083005A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors |
| 07/29/2009 | EP2082754A1 Bone defect filler, release-controlled carrier, and their production methods |
| 07/29/2009 | EP2082746A1 Extract from Urginea Maritima for use in the treatment of non small cell lung cancer (NSCLC) and other solid tumors |
| 07/29/2009 | EP2082745A1 Method for cancer therapy with a parvovirus combined with chemotherapy |
| 07/29/2009 | EP2082740A2 Use of imidazole derivatives as MDR modulators |
| 07/29/2009 | EP2082737A2 Methods of inducing terminal differentiation |
| 07/29/2009 | EP2081964A2 Alginate and alginate lyase compositions and methods of use |
| 07/29/2009 | EP2081962A2 Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease |
| 07/29/2009 | EP2081938A2 Substituted 8-piperidinyl-2-pyridinyl-pyrimido ý1,2-a¨pirimidin-6-one and 8-piperidinyl-2-pyrimidi nyl-pyrimidoý1,2,-a¨pyrimidin-6-one derivatives |
| 07/29/2009 | EP2081937A2 Triazolopyridazine protein kinase modulators |
| 07/29/2009 | EP2081931A2 Fused heterocyclic derivatives useful as inhibitors of the hepatocyte growth factor receptor |
| 07/29/2009 | EP2081928A2 Pyrrolo-pyridine kinase inhibitors |
| 07/29/2009 | EP2081918A2 Mitotic kinesin inhibitors and methods of use thereof |
| 07/29/2009 | EP2081902A1 Polymorph iii of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide |
| 07/29/2009 | EP2081895A1 Hydrobenzamide derivatives as inhibitors of hsp90 |
| 07/29/2009 | EP2081599A2 Compounds, kits and methods for conferring cytoprotection |
| 07/29/2009 | EP2081595A2 Combination treatment of cd38-expressing tumors |
| 07/29/2009 | EP2081590A2 Cancer stem cell-targeted cancer therapy |
| 07/29/2009 | EP2081586A1 Rspondins as modulators of angiogenesis and vasculogenesis |
| 07/29/2009 | EP2081565A2 Cinnamic acid, vanillic acid and benzofuran derivatives for use in the treatment of inflammation and cancer |
| 07/29/2009 | EP2081556A1 Stable imatinib compositions |
| 07/29/2009 | EP1807407B1 Aromatic amides as inhibitors of c-fms kinase |
| 07/29/2009 | EP1771177A4 Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors |
| 07/29/2009 | EP1729824B1 Phospholipid analogs for the treatment of cancers |
| 07/29/2009 | EP1641791B1 3-(guanidinocarbonyl)heterocycle derivatives, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions including them |
| 07/29/2009 | EP1549679B1 Fusion protein comprising angiopoietin receptor-binding and a multimerization domain |
| 07/29/2009 | EP1517911B1 Tumour-inhibiting platinum (ii) oxalate complexes |
| 07/29/2009 | EP1495014B1 Flavanoids derivatives as chemotherapeutic, chemopreventive, and antiangiogenic agents |
| 07/29/2009 | EP1455772B1 Medium for radical treatment of tumors, inflammatory processes, fungal infections and other affections of the tissues, diagnostic and prophylactic and method of its implementation |
| 07/29/2009 | EP1432441B1 Use of hmgb1 for the activation of dendritic cells |
| 07/29/2009 | EP1406608B1 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 07/29/2009 | EP1401473B1 Transporters comprising spaced arginine moieties |
| 07/29/2009 | EP1399221B1 Compositions comprising oestrone-3-o-sulphamate and trail (tnf-related apoptosis inducing ligand) |
| 07/29/2009 | EP1347805B1 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/29/2009 | EP1261601B1 Substituted indoles for modulating nfkb activity |
| 07/29/2009 | EP1189641B1 HUMANIZED ANTI-ErbB2 ANTIBODIES AND TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 07/29/2009 | EP1086223B1 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 07/29/2009 | EP1036327B1 HLA-E binding to CD94/NKG2+ cells |
| 07/29/2009 | CN101491536A Therapeutically useful synthetic oligonucleotides |
| 07/29/2009 | CN100519559C 6-[(substituted)phenyl]triazolopyrimidines as anticancer agents |
| 07/29/2009 | CN100519555C Novel indole derivative for alkylating specific base sequence of DNA, alkylating agent using the same and medicament |